Fecal microbiota transplant for relapsing clostridium difficile infection using a frozen inoculum from unrelated donors: A randomized, open-label, controlled pilot study

Clinical Infectious Diseases

Volumn 58, Issue 11, 2014, Pages 1515-1522

  Youngster, Ilan ^a,b   Sauk, Jenny ^a,b   Pindar, Christina ^a   Wilson, Robin G ^a   Kaplan, Jess L ^a,b   Smith, Mark B ^c   Alm, Eric J ^c   Gevers, Dirk ^d   Russell, George H ^a,b   Hohmann, Elizabeth L ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c Massachusetts Institute of Technology Cambridge   (United States)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Clostridium difficile; Fecal microbiota transplant; Frozen inoculum; Microbiome

Indexed keywords

LOPERAMIDE; OMEPRAZOLE; VANCOMYCIN;

ARTICLE; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTION; COLONOSCOPY; CONTROLLED STUDY; DIARRHEA; FECES MICROFLORA; FEMALE; HUMAN; INOCULATION; MALE; MICROBIOME; NASOGASTRIC TUBE; OPEN STUDY; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT INFECTION; ADOLESCENT; ADULT; AGED; BIOLOGICAL THERAPY; CHILD; CLOSTRIDIUM INFECTIONS; DIGESTIVE TRACT INTUBATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PEPTOCLOSTRIDIUM DIFFICILE; PROCEDURES; QUESTIONNAIRE; RECURRENT DISEASE; TREATMENT OUTCOME; UNRELATED DONORS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL THERAPY; CHILD; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COLONOSCOPY; DIARRHEA; FEMALE; HUMANS; INTUBATION, GASTROINTESTINAL; MALE; MIDDLE AGED; PILOT PROJECTS; QUESTIONNAIRES; RECURRENCE; TREATMENT OUTCOME; UNRELATED DONORS; YOUNG ADULT;

EID: 84900418033     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu135     Document Type: Article

References (31)

1. Khanna S, Baddour LM, Huskins WC, et al. The epidemiology of Clostridium difficile infection in children: a population-based study. Clin Infect Dis 2013; 56:1401-6.
2. Jarvis WR, Schlosser J, Jarvis AA, Chinn RY. National point prevalence of Clostridium difficile in US health care facility inpatients, 2008. Am J Infect Control 2009; 37:263-70.
3. Kelly CP, LaMont JT. Clostridium difficile-more difficult than ever. N Engl J Med 2008; 359:1932-40.
4. Sammons JS, Toltzis P, Zaoutis TE. Clostridium difficile infection in children. JAMA Pediatr 2013; 167:567-73.
5. Louie TJ, Miller MA, Mullane KM, et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med 2011; 364:422-31.
6. Pépin J, Routhier S, Gagnon S, Brazeau I. Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada. Clin Infect Dis 2006; 42:758-64.
7. Pépin J, Valiquette L, Gagnon S, Routhier S, Brazeau I. Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027. Am J Gastroenterol 2007; 102:2781-8.
8. Vardakas KZ, Polyzos KA, Patouni K, Rafailidis PI, Samonis G, Falagas ME. Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence. Int J Antimicrob Agents 2012; 40:1-8.
9. Rupnik M, Wilcox MH, Gerding DN. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 2009; 7:526-36.
10. Petrella LA, Sambol SP, Cheknis A, et al. Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strain. Clin Infect Dis 2012; 55:351-7.
11. Chang JY, Antonopoulos DA, Kalra A, et al. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis 2008; 197:435-8.
12. Lawley TD, Clare S, Walker AW, et al. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog 2012; 8:e1002995.
13. Aas J, Gessert CE, Bakken JS. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis 2003; 36:580-5.
14. Bakken JS, Borody T, Brandt LJ, et al. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol 2011; 9:1044-9.
15. Brandt LJ, Aroniadis OC, Mellow M, et al. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol 2012; 107:1079-87.
16. Brandt LJ, Reddy SS. Fecal microbiota transplantation for recurrent clostridium difficile infection. J Clin Gastroenterol 2011; 45(suppl): S159-67.
17. Kelly CR, de Leon L, Jasutkar N. Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results. J Clin Gastroenterol 2012; 46:145-9.
18. Mattila E, Uusitalo-Seppälä R, Wuorela M, et al. Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection. Gastroenterology 2012; 142:490-6.
19. Van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013; 368:407-15.
20. Glauser W. Risk and rewards of fecal transplants. CMAJ 2011; 183: 541-2.
21. Guo B, Harstall C, Louie T, Veldhuyzen van Zanten S, Dieleman LA. Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease. Aliment Pharmacol Ther 2012; 35: 865-75.
22. Karadsheh Z, Sule S. Fecal transplantation for the treatment of recurrent Clostridium difficile infection. N Am J Med Sci 2013; 5:339-43.
23. Kassam Z, Lee CH, Yuan Y, Hunt RH. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol 2013; 108:500-8.
24. Fridey JL, Townsend MJ, Kessler DA, Gregory KR. A question of clarity: redesigning the American Association Of Blood Banks blood donor history questionnaire-a chronology and model for donor screening. Transfus Med Rev 2007; 21:181-204.
25. Hamilton MJ, Weingarden AR, Sadowsky MJ, Khoruts A. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol 2012; 107:761-7.
26. Trotti A, Colevas AD, Setser A, et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 2003; 13:176-81.
27. Caporaso JG, Lauber CL,WaltersWA, et al. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J 2012; 6:1621-4.
28. Preheim SP, Perrotta AR, Friedman J, et al. Computational methods for high-throughput comparative analyses of natural microbial communities. Methods Enzymol 2013; 531:353-70.
29. Sammons JS, Toltzis P, Zaoutis TE. Clostridium difficile infection in children. JAMA Pediatr 2013; 167:567-73.
30. Village EG. Clostridium difficile infection in infants and children. Pediatrics 2013; 131:196-200.
31. Kelly CR, Kunde SS, Khoruts A. Guidance on preparing an Investigational New Drug application for fecal microbiota transplantation studies. Clin Gastroenterol Hepatol 2014; 12:283-8.